Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens-Reference-Cited by-同舟云学术

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

Published:2005-02-01 Issue:2 Volume:20 Page:563-568
ISSN:1460-2350
Container-title:Human Reproduction
language:en
Short-container-title:

Author:

van Vliet Huib A.A.M.,Frolich Marijke,Christella M.,Thomassen L.G.D.,Doggen Carine J.M.,Rosendaal Frits R.,Rosing Jan,Helmerhorst Frans M.

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/20/2/563/1649803/deh612.pdf

Reference22 articles.

1. Anderson DC (1974) Sex-hormone-binding globulin. Clin Endocrinol (Oxf)3, 69–96.

2. Barkfeldt J, Virkkunen A and Dieben T (2001) The effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolism. Contraception64, 295–299.

3. Crona N, Silfverstolpe G and Samsioe G (1984) Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol. Contraception29, 261–270.

4. El Makhzangy MN, Wynn V and Lawrence DM (1979) Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol (Oxf)10, 39–45.

5. Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV and Lundin FE (1991) Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol133, 32–37.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population;Communications Biology;2023-01-18

2. Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women;Climacteric;2022-11-18

3. Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis;The Journal of Clinical Endocrinology & Metabolism;2022-03-13

4. Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk;Frontiers in Endocrinology;2021-12-09

5. The Effect Of Combined Oral Contraceptives And Hormone Therapy During Assisted Reproductive Technologies On The Function Of The Hemostatic System In Non-Pregnant And Pregnant Women;Russian Open Medical Journal;2021-06-20